Alzamend Neuro's total assets for Q were $5.01M, an increase of 199.89% from the previous quarter. ALZN total liabilities were $1.25M for the fiscal quarter, a -56.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.